amitiza

SPI Subsidiary Sucampo Pharmaceuticals Received Approval in Japan for Amitiza
Dec 5, 2012
SPI subsidiary Sucampo Pharmaceuticals has received approval from the Ministry of Health, Labor and Welfare in Japan for Amitiza (lubiprostone), a prescription drug for the treatment of chronic constipation, excluding constipation caused by ...

Tags: amitiza, lubiprostone, treatment of chronic constipation, prostone
Sucampo Has Received a Supplement Approval
Dec 4, 2012
Global pharmaceutical company Sucampo has received a supplement approval from the US Food and Drug Administration (FDA) for updates to AMITIZA (lubiprostone) pregnancy labeling. The approval removes pregnancy 'warnings and precautions' ...

Tags: pharmaceutical, supplement, labeling, lubiprostone, FDA, labeling changes
Lilly Gains an Additional Six Months of Us Market Exclusivity for Cymbalta
Jul 9, 2012
The International Court of Arbitration, International Chamber of Commerce (ICC), has issued its arbitral award in the arbitration filed by R-Tech Ueno, together with Sucampo Pharmaceuticals and Sucampo, against Takeda Pharmaceutical ...

Tags: arbitration, amitiza capsule, business